Exelixis (EXEL) PT Raised to $41 at Barclays
Get Alerts EXEL Hot Sheet
Price: $54.59 +1.68%
Rating Summary:
14 Buy, 12 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
14 Buy, 12 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Barclays analyst Etzer Darout raised the price target on Exelixis (NASDAQ: EXEL) to $41.00 (from $40.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- BMO Capital Starts Exelixis (EXEL) at Market Perform
- Moderna (MRNA) PT Raised to $77 at JPMorgan
- Elastic NV. (ESTC) PT Raised to $93 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share